Skadden, Arps, Slate, Meagher & Flom LLP

General Practice. Alternative Dispute Resolution; Antitrust; Appellate Litigation and Legal Issues; Banking and Institutional Investing; Communications; Complex Mass Torts and Insurance Litigation; Consumer Financial Services Enforcement and Litigation; Corporate; Corporate Compliance Programs; Corporate Finance; Corporate Governance; Corporate Restructuring; Derivative Financial Products, Commodities and Futures; Employee Benefits and Executive Compensation; Energy Project Finance and Development; Energy Regulatory; Environmental; Environmental Litigation; European Union/International Competition; Financial Institutions; Financial Services ; Franchise Law; Gaming; Government Contract Disputes; Government Enforcement Litigation; Health Care; Health Care Enforcement and Litigation; Health Care Fraud and Abuse; Information Technology and E-Commerce; Insurance; Intellectual Property and Technology; International Arbitration; International Law and Policy; International Tax; International Trade; Investment Management; Labor and Employment; Lease Financing; Litigation; Mergers and Acquisitions; Outsourcing; Patent and Technology Litigation and Counseling; Pharmaceutical, Biotechnology and Medical Device Licensing; Political Law; Private Equity; Private Investment Funds; Privatizations; Products Liability; Public Policy; Real Estate; Real Estate Investment Trusts; Securities Enforcement and Compliance; Securities Litigation; Sports; Structured Finance; Tax; Tax Controversy and Litigation; Trademark, Copyright, and Advertising Litigation and Counseling; Trusts and Estates; Uniformed Commercial Code and Secured Transactions; Utilities Mergers and Acquisitions; White Collar Crime.

FDA Schedules Public Hearing on the Use of the Internet and Social Media in the Promotion of FDA-Regulated Products
John T. Bentivoglio, Jennifer L. Bragg, Jose A. Esteves, Stuart D. Levi, Gregory M. Luce, November 9, 2009
The United States Food and Drug Administration (FDA) has issued a notice of public hearing and request for comments to discuss issues related to the promotion of FDA-regulated products (e.g., prescription drugs, prescription biologics and medical devices) using the Internet and social media tools....

"Corporate Governance and Tax Risk"
Peter Allan Atkins, Fred T. Goldberg, Armando Gomez, Pamela F. Olson, October 27, 2009
On October 19, 2009, IRS Commissioner Douglas H. Shulman delivered a speech to the National Association of Corporate Directors (NACD) in which he encouraged boards of directors to focus greater attention on oversight of tax risk.1 This memorandum highlights some of the key points from the...

"Recent Developments in Private Equity Involvement in FDIC Resolutions"
David C. Ingles, William S. Rubenstein, William J. Sweet, October 27, 2009
In a transaction that establishes a new paradigm for FDIC auctions of failed institutions, a consortium of private equity firms consisting of Starwood Capital Group, TPG Capital, Perry Capital and a joint venture betweenWL Ross & Co. and LeFrak Organization recently completed the acquisition of...

Return to the Skadden, Arps, Slate, Meagher & Flom LLP Firm Overview